Sionna Therapeutics Inc.
Clinical trials sponsored by Sionna Therapeutics Inc., explained in plain language.
-
Early testing begins on potential cystic fibrosis treatment
Disease control Recruiting nowThis early-stage study is testing the safety of new drug combinations (SION-451 with SION-2222 or SION-109) in healthy volunteers. The goal is to understand how these potential cystic fibrosis treatments are tolerated by the body before testing in patients. Researchers will monit…
Phase: PHASE1 • Sponsor: Sionna Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 23:31 UTC
-
New pill aims to boost power of leading CF drug
Disease control Recruiting nowThis study is testing if adding an experimental drug called SION-719 to the standard medication Trikafta is safe and works better for people with cystic fibrosis who have a specific genetic type. It will involve about 16 people who are already taking Trikafta. Researchers will ch…
Phase: PHASE2 • Sponsor: Sionna Therapeutics Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC